SMYD5 acts as a potential biomarker for hepatocellular carcinoma.
Sign Up to like & getrecommendations! Published in 2022 at "Experimental cell research"
DOI: 10.1016/j.yexcr.2022.113076
Abstract: Determining the prognosis of patients remains a challenge due to the phenotypic and molecular diversities of hepatocellular carcinomas (HCC). We aimed to evaluate the role of SMYD5 in HCC. Wilcoxon signed-rank test and logistic regression… read more here.
Keywords: smyd5; hcc; potential biomarker; acts potential ... See more keywords
Unique SMYD5 Structure Revealed by AlphaFold Correlates with Its Functional Divergence
Sign Up to like & getrecommendations! Published in 2022 at "Biomolecules"
DOI: 10.3390/biom12060783
Abstract: SMYD5 belongs to a special class of protein lysine methyltransferases with an MYND (Myeloid-Nervy-DEAF1) domain inserted into a SET (Suppressor of variegation, Enhancer of Zeste, Trithorax) domain. Despite recent advances in its functional characterization, the… read more here.
Keywords: structure; smyd5; unique smyd5; smyd5 structure ... See more keywords